Your browser doesn't support javascript.
loading
Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery in patients with locally advanced esophageal squamous cell carcinoma who achieved clinical complete response when induction chemoradiation finished: A phase II random.
Qian, Dong; Chen, Xi; Shang, Xiaobin; Wang, Yuwen; Tang, Peng; Han, Dong; Jiang, Hongjing; Chen, Chuangui; Zhao, Gang; Zhou, Dejun; Cao, Fuliang; Er, Puchun; Zhang, Wencheng; Li, Xiaoxia; Zhang, Tian; Zhang, Baozhong; Guan, Yong; Wang, Jun; Yuan, Zhiyong; Yu, Zhentao; Wang, Ping; Pang, Qingsong.
Affiliation
  • Qian D; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, China; Department of Radiation Oncology, the First Affili
  • Chen X; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, China.
  • Shang X; Department of Esophageal Cancer, Tianjin Medical University Cancer Institute and Hospital, China.
  • Wang Y; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, China.
  • Tang P; Department of Esophageal Cancer, Tianjin Medical University Cancer Institute and Hospital, China.
  • Han D; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, China.
  • Jiang H; Department of Esophageal Cancer, Tianjin Medical University Cancer Institute and Hospital, China.
  • Chen C; Department of Esophageal Cancer, Tianjin Medical University Cancer Institute and Hospital, China.
  • Zhao G; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, China.
  • Zhou D; Department of Endoscopy Diagnosis and Therapy, Tianjin Medical University Cancer Institute and Hospital, China.
  • Cao F; Department of Endoscopy Diagnosis and Therapy, Tianjin Medical University Cancer Institute and Hospital, China.
  • Er P; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, China.
  • Zhang W; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, China.
  • Li X; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, China.
  • Zhang T; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, China.
  • Zhang B; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, China.
  • Guan Y; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, China.
  • Wang J; Department of Radiotherapy, Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Yuan Z; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, China.
  • Yu Z; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China. Electronic address: yuzhentao@tjmuch.com.
  • Wang P; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, China. Electronic address: wangping@163.com.
  • Pang Q; Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, China. Electronic address: pangqingsong@tjmuch.com.
Radiother Oncol ; 174: 1-7, 2022 09.
Article in En | MEDLINE | ID: mdl-35764191
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Esophageal Squamous Cell Carcinoma Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Radiother Oncol Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Esophageal Squamous Cell Carcinoma Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Radiother Oncol Year: 2022 Document type: Article Country of publication: